Annual CAPEX
$730.00 K
+$143.00 K+24.36%
31 December 2023
Summary:
LAVA Therapeutics NV annual capital expenditures is currently $730.00 thousand, with the most recent change of +$143.00 thousand (+24.36%) on 31 December 2023. During the last 3 years, it has risen by +$228.00 thousand (+45.42%). LVTX annual CAPEX is now -4.45% below its all-time high of $764.00 thousand, reached on 31 December 2021.LVTX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
N/A
30 September 2024
Summary:
LAVA Therapeutics NV quarterly capital expenditures is not available.LVTX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
N/A
30 September 2024
Summary:
LAVA Therapeutics NV TTM capital expenditures is not available.LVTX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LVTX CAPEX Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +24.4% | - | - |
3 y3 years | +45.4% | - | - |
5 y5 years | - | - | - |
LVTX CAPEX High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -4.5% | +45.4% | ||||
5 y | 5 years | -4.5% | +45.4% | ||||
alltime | all time | -4.5% | +45.4% |
LAVA Therapeutics NV CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2023 | $730.00 K(+24.4%) | $0.00(-100.0%) | $730.00 K(-26.6%) |
Sept 2023 | - | $6000.00(-97.3%) | $995.00 K(+3.2%) |
June 2023 | - | $224.00 K(-55.2%) | $964.00 K(+26.2%) |
Mar 2023 | - | $500.00 K(+88.7%) | $764.00 K(+30.2%) |
Dec 2022 | $587.00 K | $265.00 K(-1160.0%) | $587.00 K(+19.8%) |
Sept 2022 | - | -$25.00 K(-204.2%) | $490.00 K(-47.7%) |
June 2022 | - | $24.00 K(-92.6%) | $937.00 K(+1.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | $323.00 K(+92.3%) | $921.00 K(+20.5%) |
Dec 2021 | $764.00 K(+52.2%) | $168.00 K(-60.2%) | $764.00 K(+16.8%) |
Sept 2021 | - | $422.00 K(+5175.0%) | $654.20 K(+27.0%) |
June 2021 | - | $8000.00(-95.2%) | $515.20 K(-3.6%) |
Mar 2021 | - | $166.00 K(+185.2%) | $534.60 K(+45.0%) |
Dec 2020 | $502.00 K | $58.20 K(-79.4%) | $368.60 K(+18.8%) |
Sept 2020 | - | $283.00 K(+932.8%) | $310.40 K(+1032.8%) |
June 2020 | - | $27.40 K | $27.40 K |
FAQ
- What is LAVA Therapeutics NV annual capital expenditures?
- What is the all time high annual CAPEX for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV annual CAPEX year-on-year change?
- What is the all time high quarterly CAPEX for LAVA Therapeutics NV?
- What is the all time high TTM CAPEX for LAVA Therapeutics NV?
What is LAVA Therapeutics NV annual capital expenditures?
The current annual CAPEX of LVTX is $730.00 K
What is the all time high annual CAPEX for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high annual capital expenditures is $764.00 K
What is LAVA Therapeutics NV annual CAPEX year-on-year change?
Over the past year, LVTX annual capital expenditures has changed by +$143.00 K (+24.36%)
What is the all time high quarterly CAPEX for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high quarterly capital expenditures is $500.00 K
What is the all time high TTM CAPEX for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high TTM capital expenditures is $995.00 K